- Previous Close
39.00 - Open
38.98 - Bid 39.12 x --
- Ask 39.20 x --
- Day's Range
38.81 - 39.73 - 52 Week Range
36.43 - 48.00 - Volume
65,478 - Avg. Volume
33,653 - Market Cap (intraday)
1.535B - Beta (5Y Monthly) 0.75
- PE Ratio (TTM)
24.75 - EPS (TTM)
1.58 - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield 0.44 (1.13%)
- Ex-Dividend Date Mar 31, 2025
- 1y Target Est
49.08
Andlauer Healthcare Group Inc., a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics. It provides logistics and distribution services, including client and customer integration, transportation and inventory management, distribution and fulfillment, and warehousing solutions; and packaging services, such as co-packing and re-packing, assembly, and custom work services, as well as design, supply, and secondary Rx packaging services. The company also offers temperature-controlled services; air freight forwarding services; dedicated and last mile delivery services; and ground transportation services, including less-than-truckload, pick-up and delivery, and courier services, as well as carrier options. It serves healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. The company was founded in 1991 and is headquartered in Vaughan, Canada. Andlauer Healthcare Group Inc. operates as a subsidiary of Andlauer Management Group Inc.
andlauerhealthcare.com2,380
Full Time Employees
December 31
Fiscal Year Ends
Sector
Integrated Freight & Logistics
Industry
Recent News: AND.TO
View MorePerformance Overview: AND.TO
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AND.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AND.TO
View MoreValuation Measures
Market Cap
1.53B
Enterprise Value
1.68B
Trailing P/E
24.68
Forward P/E
22.03
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.45
Price/Book (mrq)
3.55
Enterprise Value/Revenue
2.57
Enterprise Value/EBITDA
10.03
Financial Highlights
Profitability and Income Statement
Profit Margin
9.91%
Return on Assets (ttm)
8.52%
Return on Equity (ttm)
14.32%
Revenue (ttm)
650.48M
Net Income Avi to Common (ttm)
64.47M
Diluted EPS (ttm)
1.58
Balance Sheet and Cash Flow
Total Cash (mrq)
40.48M
Total Debt/Equity (mrq)
42.03%
Levered Free Cash Flow (ttm)
97.76M